GVK Biosciences Pvt Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:GVK Biosciences Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013932
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GVK Biosciences Pvt Ltd (GVK BIO) is a contract research organization that offers contract manufacturing and research services. The organization provides services such as discovery services, integrated programs, clinical development, contract manufacturing, formulations and informatics. It provides distribution assays, animal models, assay development and screening, regulatory affairs services, report writing services, clinical operations services, clinical pharmacology, clinical research, clinical trial outcome database, and others. GVK BIO offers contract research services to its clientele from various sectors including pharmaceutical, agrochemical, electronics, biotechnology and academics. The organization operates through offices in India, the US and the Netherlands. GVK BIO is headquartered in Hyderabad, Telangana, India.

GVK Biosciences Pvt Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
GVK Biosciences Pvt Ltd, Medical Devices Deals, 2011 to YTD 2017 9
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Aragen Bioscience Raises US$2.7 Million In Venture Financing 11
Private Equity 12
ChrysCapital Management Acquires 10% stake in GVK Bio 12
Partnerships 13
Medivir Enters into Research Agreement with GVK Biosciences 13
GVK Biosciences Forms Joint Venture with Takeda Pharma 14
Aragen Bioscience Enters Into Co-Development Agreement With Innovent Biologics For Biotherapeutic Products 15
GVK Biosciences Enters Into Research Agreement With Endo Pharma 16
GVK Biosciences Enters Into Agreement With Onconova Therapeutics To Develop New Cancer Drugs 17
GVK Biosciences Enters Into Drug Discovery Agreement With Moulder Center for Drug Discovery Research 18
Licensing Agreements 19
Aragen Bioscience Enters into Licensing Agreement with ProteoNic Biotech 19
University Of Dundee Enters Into Licensing Agreement With GVK Biosciences For Gostar 20
GVK Biosciences Extends Licensing Agreement With Astellas Pharma 21
Acquisition 22
GVK Biosciences to Acquire Vanta Bioscience for USD5 Million 22
GVK Biosciences Acquires Remaining 6.12% Stake in Inogent Labs from Dai-Ichi Karkaria 23
GVK Biosciences Acquires Aragen Bioscience, Contract Research Organization 24
GVK Biosciences Plans To Acquire Spectrum Biosciences 25
GVK Biosciences Pvt Ltd – Key Competitors 26
GVK Biosciences Pvt Ltd – Key Employees 27
GVK Biosciences Pvt Ltd – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Key Facts 2
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GVK Biosciences Pvt Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
GVK Biosciences Pvt Ltd, Medical Devices Deals, 2011 to YTD 2017 9
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aragen Bioscience Raises US$2.7 Million In Venture Financing 11
ChrysCapital Management Acquires 10% stake in GVK Bio 12
Medivir Enters into Research Agreement with GVK Biosciences 13
GVK Biosciences Forms Joint Venture with Takeda Pharma 14
Aragen Bioscience Enters Into Co-Development Agreement With Innovent Biologics For Biotherapeutic Products 15
GVK Biosciences Enters Into Research Agreement With Endo Pharma 16
GVK Biosciences Enters Into Agreement With Onconova Therapeutics To Develop New Cancer Drugs 17
GVK Biosciences Enters Into Drug Discovery Agreement With Moulder Center for Drug Discovery Research 18
Aragen Bioscience Enters into Licensing Agreement with ProteoNic Biotech 19
University Of Dundee Enters Into Licensing Agreement With GVK Biosciences For Gostar 20
GVK Biosciences Extends Licensing Agreement With Astellas Pharma 21
GVK Biosciences to Acquire Vanta Bioscience for USD5 Million 22
GVK Biosciences Acquires Remaining 6.12% Stake in Inogent Labs from Dai-Ichi Karkaria 23
GVK Biosciences Acquires Aragen Bioscience, Contract Research Organization 24
GVK Biosciences Plans To Acquire Spectrum Biosciences 25
GVK Biosciences Pvt Ltd, Key Competitors 26
GVK Biosciences Pvt Ltd, Key Employees 27
GVK Biosciences Pvt Ltd, Other Locations 28
GVK Biosciences Pvt Ltd, Subsidiaries 28

★海外企業調査レポート[GVK Biosciences Pvt Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Laerdal Medical AS:企業の戦略的SWOT分析
    Laerdal Medical AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Multan Electric Power Company:発電所・企業SWOT分析
    Multan Electric Power Company – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Congenica Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Congenica Ltd (Congenica) is a biotechnology company that offers clinical decision support software and services. The company provides research and experimental development on biotechnology. Its technology SAPIENTIA is used to personalize patient care through accurate diagnoses, drug develop …
  • DexCom Inc (DXCM):企業の製品パイプライン分析
    Summary Dexcom Inc (Dexcom) is a medical device company that designs, develops and commercializes continuous glucose monitoring (CGM) systems. The company’s major products include integrated CGM systems for adults and pediatric use, Dexcom G5 mobile CGM system, Dexcom G4 PLATINUM CGM system, associa …
  • Impol Seval A.D. Sevojno:企業の戦略・SWOT・財務分析
    Impol Seval A.D. Sevojno - Strategy, SWOT and Corporate Finance Report Summary Impol Seval A.D. Sevojno - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Shimadzu Corp (7701):医療機器:M&Aディール及び事業提携情報
    Summary Shimadzu Corp (Shimadzu) is a manufacturer of precision instruments, measuring instruments and medical equipment. The company’s product portfolio includes high performance liquid chromatographs (HPLC), spectrometers, carbon analyzer, X-ray systems, inspection systems, semiconductor manufactu …
  • Sumitomo Heavy Industries, Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • ENCE Energia Y Celulosa SA (ENC):企業の財務・戦略的SWOT分析
    ENCE Energia Y Celulosa SA (ENC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Minerals Technologies Inc (MTX):企業の財務・戦略的SWOT分析
    Minerals Technologies Inc (MTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • ITC Holdings Corp.:企業の発電所・SWOT分析2018
    ITC Holdings Corp. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Holtec International Inc:電力:M&Aディール及び事業提携情報
    Summary Holtec International, Inc. (Holtec) is a diversified energy technology company. It supplies equipment and systems for the nuclear, solar, geothermal and fossil power generation sectors of the energy industry. The company’s products and service portfolio includes advanced technology solutions …
  • VIA Technologies Inc (2388):企業の財務・戦略的SWOT分析
    VIA Technologies Inc (2388) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • CH2M HILL Companies, Ltd.:戦略・SWOT・企業財務分析
    CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report Summary CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • AnGes Inc (4563):製薬・医療:M&Aディール及び事業提携情報
    Summary AnGes Inc (AnGes) is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specializes in research and development (R&D) and practical application of genetic medicine. It has two …
  • Immunomedics Inc (IMMU):企業の財務・戦略的SWOT分析
    Immunomedics Inc (IMMU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Croma-Pharma GmbH-医療機器分野:企業M&A・提携分析
    Summary Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company which focuses on the development and commercialization of drugs in the field of aesthetic dermatology. It offers princess injectables, princess skincare, and princess lift products. The company’s princess skincare products comprise …
  • Geisinger:医療機器:M&Aディール及び事業提携情報
    Summary Geisinger formerly, Geisinger Health System is an integrated health services organization that provides medical and surgical specialties and sub-specialties, and related health services. It offers medical services for patients related to cardiology, ENT, gastroenterology, gynecology, cancer, …
  • UTair Aviation:企業の戦略・SWOT・財務情報
    UTair Aviation - Strategy, SWOT and Corporate Finance Report Summary UTair Aviation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Tosoh Corp (4042):企業の財務・戦略的SWOT分析
    Tosoh Corp (4042) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Collegium Pharmaceutical Inc (COLL):企業の財務・戦略的SWOT分析
    Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆